Living with chronic hives can be frustrating, especially when symptoms interfere with daily life. Research studies like EMBARQ are designed to explore new approaches for people whose symptoms continue despite antihistamines.
This Phase 3 trial is evaluating an investigational injectable medication for adults with cold-induced urticaria and symptomatic dermographism. By participating, volunteers help researchers learn more about these conditions and work toward new treatment possibilities.
Clinical trials follow strict ethical guidelines, and participants remain in control of their involvement every step of the way. For some individuals, research offers a chance to contribute to science while receiving structured study support.